Abstract
The field of neurogenetics has been revolutionized by the advances in genome-wide association testing. Recent gene discoveries for disorders of neurodegeneration, CNS demyelination, and neurodevelopmental and cerebrovascular syndromes begin to shape our understanding of the complexity of their underlying genetic architecture. In the future, this knowledge should advance risk prediction, prevention, diagnosis, and treatment strategies for patients with neurologic disorders and their families.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
